Stock listing
Cboe Canada:RVV Revive Therapeutics Ltd. Stock
Canadian listing (Cboe Canada) of Revive Therapeutics Ltd. · home listing CSE:RVV
Follow Revive Therapeutics Ltd. into a list and get an email when it puts out news.
Home listing price · CSE:RVV
$0.02 CAD +0.01 (+33.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:RVV
- Day range
- $0.02 – $0.02 CADOct 30, 2026
- Volume
- 212,393 sharesOct 30, 2026
- Market cap
- $8.71M CADAt the close on Oct 30, 2026 · price × 435.7M shares outstanding
- 52-week range
- $0.0050 – $0.08 CADLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $4,540 CADMedian day 93,400 shares · 3 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:RVV · Home | $0.02 CAD | +0.005 (+33.3%) | 212,393 | $0.02 | $0.02 | $0.02 | $0.015 | Close on Oct 30, 2026 |
| OTC:RVVTF | $0.017 USD | +0.003 (+19.7%) | 28,000 | $0.015 | $0.017 | $0.015 | $0.014 | Close on Oct 27, 2026 |
| Frankfurt:31R | €0.0045 EUR | -0.0035 (-43.8%) | — | €0.0020 | €0.0045 | €0.0020 | €0.0080 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · CSE:RVV · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.02 | +0.005 | +33.3% | $0.02 | $0.02 | $0.02 | 212,393 | |
| $0.015 | -0.005 | -25.0% | $0.025 | $0.025 | $0.015 | 61,940 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.02 | $0.02 | 81,000 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.02 | $0.02 | 98,000 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.02 | $0.02 | 88,800 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.025 | $0.02 | 355,859 | |
| $0.02 | -0.005 | -20.0% | $0.02 | $0.02 | $0.02 | 677,356 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 0 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 1,654 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 15,000 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 10,000 | |
| $0.03 | +0.005 | +20.0% | $0.03 | $0.03 | $0.03 | 3,260 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 113,000 | |
| $0.03 | +0.005 | +20.0% | $0.03 | $0.03 | $0.03 | 6,664 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 60,830 | |
| $0.03 | +0.005 | +20.0% | $0.03 | $0.03 | $0.03 | 204,725 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 13,800 | |
| $0.03 | 0.00 | 0.0% | $0.03 | $0.03 | $0.03 | 111,515 | |
| $0.03 | +0.005 | +20.0% | $0.03 | $0.03 | $0.03 | 9,496 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.02 | 38,930 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 6,000 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.02 | 132,000 | |
| $0.03 | +0.01 | +50.0% | $0.025 | $0.03 | $0.025 | 652,865 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.02 | $0.02 | 104,580 | |
| $0.02 | -0.005 | -20.0% | $0.02 | $0.02 | $0.02 | 6,110 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 0 | |
| $0.025 | +0.005 | +25.0% | $0.025 | $0.025 | $0.025 | 14,000 | |
| $0.02 | -0.005 | -20.0% | $0.025 | $0.025 | $0.02 | 124,358 | |
| $0.025 | +0.005 | +25.0% | $0.02 | $0.025 | $0.02 | 6,839 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.02 | $0.02 | 195,000 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.025 | $0.02 | 105,720 | |
| $0.02 | 0.00 | 0.0% | $0.02 | $0.02 | $0.02 | 262,176 | |
| $0.02 | +0.005 | +33.3% | $0.02 | $0.02 | $0.02 | 422,160 | |
| $0.015 | -0.01 | -40.0% | $0.025 | $0.025 | $0.015 | 1,850,378 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 1,080 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 198,480 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 29,098 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 132,100 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 26,500 | |
| $0.03 | +0.005 | +20.0% | $0.03 | $0.03 | $0.03 | 6,070 | |
| $0.025 | +0.005 | +25.0% | $0.025 | $0.025 | $0.025 | 2,000 | |
| $0.02 | -0.005 | -20.0% | $0.025 | $0.025 | $0.02 | 71,900 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 36,384 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 31,000 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 363,000 | |
| $0.03 | +0.005 | +20.0% | $0.025 | $0.03 | $0.025 | 62,739 | |
| $0.025 | 0.00 | 0.0% | $0.03 | $0.03 | $0.025 | 589,200 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 267,100 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.025 | $0.025 | 268,000 | |
| $0.03 | +0.005 | +20.0% | $0.03 | $0.03 | $0.03 | 132,000 | |
| $0.025 | -0.005 | -16.7% | $0.03 | $0.03 | $0.025 | 398,195 | |
| $0.03 | 0.00 | 0.0% | $0.03 | $0.03 | $0.03 | 132,000 | |
| $0.03 | 0.00 | 0.0% | $0.03 | $0.035 | $0.03 | 702,504 | |
| $0.03 | 0.00 | 0.0% | $0.03 | $0.03 | $0.03 | 71,000 | |
| $0.03 | -0.005 | -14.3% | $0.03 | $0.03 | $0.03 | 363,000 | |
| $0.035 | +0.005 | +16.7% | $0.03 | $0.035 | $0.03 | 878,720 | |
| $0.03 | +0.005 | +20.0% | $0.025 | $0.03 | $0.025 | 656,014 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 64,604 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 52,000 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 110,000 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.03 | $0.025 | 114,596 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 21,000 | |
| $0.025 | 0.00 | 0.0% | $0.025 | $0.025 | $0.025 | 0 | |
| $0.025 | -0.005 | -16.7% | $0.025 | $0.03 | $0.025 | 146,342 |
- Ticker
- Cboe Canada:RVV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
What changed lately
Latest news release · Sep 15, 2026
Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 16 slides
Latest news
Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
Sep 15, 2026
Closed $0.02 (+33.3%) on Sep 15, 2026
Revive Therapeutics Announces Proposed Shares for Debt Settlement
Aug 19, 2026
Closed $0.025 (-16.7%) on Aug 19, 2026
Revive Therapeutics Reports Grant of Options
Aug 14, 2026
Closed $0.03 (0.0%) on Aug 17, 2026
Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study
Aug 12, 2026
Closed $0.035 (+16.7%) on Aug 12, 2026
Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
Jul 15, 2026
Closed $0.03 (0.0%) on Jul 16, 2026
Revive Therapeutics Announces Proposed Private Placement
Jun 26, 2026
Closed $0.03 (0.0%) on Jun 29, 2026
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
May 20, 2026
Closed $0.04 (+33.3%) on May 20, 2026
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Dec 15, 2025
Closed $0.015 (0.0%) on Dec 15, 2025
Financings
Private placement of units
Jul 15, 2026 · US$175,756
Tranche closed: C$246,920 raised · C$0.032 a unit · 1 warrant at C$0.05 for 36 months
Use of proceeds: Primarily working capital
Decks
Investor Presentation (August 2026)
Investor deck · 16 slides · August 2026
Investor Presentation (March 2026)
Investor deck · 13 slides · March 2026
Investor Presentation (February 2026)
Investor deck · 13 slides · February 2026
Investor Presentation (May 2025)
Investor deck · 15 slides · May 2025
Revive Therapeutics Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 8 in the last 12 months · 23 in all · newest Sep 15, 2026 · oldest 2014
- Decks
- 32 decks · latest August 2026
Where Revive Therapeutics Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:RVV · Home listing | CSE | Canada | CAD |
| OTC:RVVTF | OTC | United States | USD |
| gettex:31R | gettex | Germany | EUR |
| Cboe Canada:RVV · This page | Cboe Canada | Canada | CAD |
| LS Exchange:A2AP4F | LS Exchange | Germany | EUR |
| Frankfurt:31R | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2AP4F | Lang & Schwarz | Germany | EUR |
| Munich:31R | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Revive Therapeutics Ltd.